2588 related articles for article (PubMed ID: 23150908)
1. Variant of TREM2 associated with the risk of Alzheimer's disease.
Jonsson T; Stefansson H; Steinberg S; Jonsdottir I; Jonsson PV; Snaedal J; Bjornsson S; Huttenlocher J; Levey AI; Lah JJ; Rujescu D; Hampel H; Giegling I; Andreassen OA; Engedal K; Ulstein I; Djurovic S; Ibrahim-Verbaas C; Hofman A; Ikram MA; van Duijn CM; Thorsteinsdottir U; Kong A; Stefansson K
N Engl J Med; 2013 Jan; 368(2):107-16. PubMed ID: 23150908
[TBL] [Abstract][Full Text] [Related]
2. TREM2 variants in Alzheimer's disease.
Guerreiro R; Wojtas A; Bras J; Carrasquillo M; Rogaeva E; Majounie E; Cruchaga C; Sassi C; Kauwe JS; Younkin S; Hazrati L; Collinge J; Pocock J; Lashley T; Williams J; Lambert JC; Amouyel P; Goate A; Rademakers R; Morgan K; Powell J; St George-Hyslop P; Singleton A; Hardy J;
N Engl J Med; 2013 Jan; 368(2):117-27. PubMed ID: 23150934
[TBL] [Abstract][Full Text] [Related]
3. R47H Variant of TREM2 Associated With Alzheimer Disease in a Large Late-Onset Family: Clinical, Genetic, and Neuropathological Study.
Korvatska O; Leverenz JB; Jayadev S; McMillan P; Kurtz I; Guo X; Rumbaugh M; Matsushita M; Girirajan S; Dorschner MO; Kiianitsa K; Yu CE; Brkanac Z; Garden GA; Raskind WH; Bird TD
JAMA Neurol; 2015 Aug; 72(8):920-7. PubMed ID: 26076170
[TBL] [Abstract][Full Text] [Related]
4. Coding variants in TREM2 increase risk for Alzheimer's disease.
Jin SC; Benitez BA; Karch CM; Cooper B; Skorupa T; Carrell D; Norton JB; Hsu S; Harari O; Cai Y; Bertelsen S; Goate AM; Cruchaga C
Hum Mol Genet; 2014 Nov; 23(21):5838-46. PubMed ID: 24899047
[TBL] [Abstract][Full Text] [Related]
5. Association study of TREM2 polymorphism rs75932628 with late-onset Alzheimer's disease in Chinese Han population.
Ma J; Zhou Y; Xu J; Liu X; Wang Y; Deng Y; Wang G; Xu W; Ren R; Liu X; Zhang Y; Wang C; Tang H; Chen S
Neurol Res; 2014 Oct; 36(10):894-6. PubMed ID: 24725293
[TBL] [Abstract][Full Text] [Related]
6. TREM2 R47H variant as a risk factor for early-onset Alzheimer's disease.
Pottier C; Wallon D; Rousseau S; Rovelet-Lecrux A; Richard AC; Rollin-Sillaire A; Frebourg T; Campion D; Hannequin D
J Alzheimers Dis; 2013; 35(1):45-9. PubMed ID: 23380991
[TBL] [Abstract][Full Text] [Related]
7. More evidence for association of a rare TREM2 mutation (R47H) with Alzheimer's disease risk.
Rosenthal SL; Bamne MN; Wang X; Berman S; Snitz BE; Klunk WE; Sweet RA; Demirci FY; Lopez OL; Kamboh MI
Neurobiol Aging; 2015 Aug; 36(8):2443.e21-6. PubMed ID: 26058841
[TBL] [Abstract][Full Text] [Related]
8. Frontobasal gray matter loss is associated with the TREM2 p.R47H variant.
Luis EO; Ortega-Cubero S; Lamet I; Razquin C; Cruchaga C; Benitez BA; Lorenzo E; Irigoyen J; ; Pastor MA; Pastor P
Neurobiol Aging; 2014 Dec; 35(12):2681-2690. PubMed ID: 25027412
[TBL] [Abstract][Full Text] [Related]
9. Assessment of TREM2 rs75932628 association with Alzheimer's disease in a population-based sample: the Cache County Study.
Gonzalez Murcia JD; Schmutz C; Munger C; Perkes A; Gustin A; Peterson M; Ebbert MT; Norton MC; Tschanz JT; Munger RG; Corcoran CD; Kauwe JS
Neurobiol Aging; 2013 Dec; 34(12):2889.e11-3. PubMed ID: 23855982
[TBL] [Abstract][Full Text] [Related]
10.
Durmanova V; Javor J; Parnicka Z; Minarik G; Ocenasova A; Vaseckova B; Kiralyova I; Sutovsky S; Petrovic R; Shawkatova I
J Integr Neurosci; 2022 Jun; 21(4):105. PubMed ID: 35864757
[TBL] [Abstract][Full Text] [Related]
11. TREM2 variants and risk of Alzheimer's disease: a meta-analysis.
Lu Y; Liu W; Wang X
Neurol Sci; 2015 Oct; 36(10):1881-8. PubMed ID: 26037549
[TBL] [Abstract][Full Text] [Related]
12. Investigation of triggering receptor expressed on myeloid cells 2 variant in the Wisconsin Registry for Alzheimer's Prevention.
Engelman CD; Koscik RL; Jonaitis EM; Hermann BP; La Rue A; Sager MA
Neurobiol Aging; 2014 Jun; 35(6):1252-4. PubMed ID: 24378087
[TBL] [Abstract][Full Text] [Related]
13. Assessing the role of the TREM2 p.R47H variant as a risk factor for Alzheimer's disease and frontotemporal dementia.
Ruiz A; Dols-Icardo O; Bullido MJ; Pastor P; Rodríguez-Rodríguez E; López de Munain A; de Pancorbo MM; Pérez-Tur J; Alvarez V; Antonell A; López-Arrieta J; Hernández I; Tárraga L; Boada M; Lleó A; Blesa R; Frank-García A; Sastre I; Razquin C; Ortega-Cubero S; Lorenzo E; Sánchez-Juan P; Combarros O; Moreno F; Gorostidi A; Elcoroaristizabal X; Baquero M; Coto E; Sánchez-Valle R; Clarimón J;
Neurobiol Aging; 2014 Feb; 35(2):444.e1-4. PubMed ID: 24041969
[TBL] [Abstract][Full Text] [Related]
14. The rare TREM2 R47H variant exerts only a modest effect on Alzheimer disease risk.
Hooli BV; Parrado AR; Mullin K; Yip WK; Liu T; Roehr JT; Qiao D; Jessen F; Peters O; Becker T; Ramirez A; Lange C; Bertram L; Tanzi RE
Neurology; 2014 Oct; 83(15):1353-8. PubMed ID: 25186855
[TBL] [Abstract][Full Text] [Related]
15. Lack of association between triggering receptor expressed on myeloid cells 2 polymorphism rs75932628 and late-onset Alzheimer's disease in a Chinese Han population.
Wang P; Guo Q; Zhou Y; Chen K; Xu Y; Ding D; Hong Z; Zhao Q
Psychiatr Genet; 2018 Feb; 28(1):16-18. PubMed ID: 29256968
[TBL] [Abstract][Full Text] [Related]
16. Expression and processing analyses of wild type and p.R47H TREM2 variant in Alzheimer's disease brains.
Ma L; Allen M; Sakae N; Ertekin-Taner N; Graff-Radford NR; Dickson DW; Younkin SG; Sevlever D
Mol Neurodegener; 2016 Nov; 11(1):72. PubMed ID: 27887626
[TBL] [Abstract][Full Text] [Related]
17. Differential splicing of neuronal genes in a Trem2*R47H mouse model mimics alterations associated with Alzheimer's disease.
Pandey RS; Kotredes KP; Sasner M; Howell GR; Carter GW
BMC Genomics; 2023 Apr; 24(1):172. PubMed ID: 37016304
[TBL] [Abstract][Full Text] [Related]
18. R47H TREM2 variant increases risk of typical early-onset Alzheimer's disease but not of prion or frontotemporal dementia.
Slattery CF; Beck JA; Harper L; Adamson G; Abdi Z; Uphill J; Campbell T; Druyeh R; Mahoney CJ; Rohrer JD; Kenny J; Lowe J; Leung KK; Barnes J; Clegg SL; Blair M; Nicholas JM; Guerreiro RJ; Rowe JB; Ponto C; Zerr I; Kretzschmar H; Gambetti P; Crutch SJ; Warren JD; Rossor MN; Fox NC; Collinge J; Schott JM; Mead S
Alzheimers Dement; 2014 Nov; 10(6):602-608.e4. PubMed ID: 25160042
[TBL] [Abstract][Full Text] [Related]
19. Investigating the role of rare heterozygous TREM2 variants in Alzheimer's disease and frontotemporal dementia.
Cuyvers E; Bettens K; Philtjens S; Van Langenhove T; Gijselinck I; van der Zee J; Engelborghs S; Vandenbulcke M; Van Dongen J; Geerts N; Maes G; Mattheijssens M; Peeters K; Cras P; Vandenberghe R; De Deyn PP; Van Broeckhoven C; Cruts M; Sleegers K;
Neurobiol Aging; 2014 Mar; 35(3):726.e11-9. PubMed ID: 24119542
[TBL] [Abstract][Full Text] [Related]
20. APOE ε4 is also required in TREM2 R47H variant carriers for Alzheimer's disease to develop.
Murray CE; King A; Troakes C; Hodges A; Lashley T
Neuropathol Appl Neurobiol; 2019 Feb; 45(2):183-186. PubMed ID: 29411406
[No Abstract] [Full Text] [Related]
[Next] [New Search]
